Charles Rhyee
Stock Analyst at TD Cowen
(4.03)
# 1,722
Out of 5,022 analysts
660
Total ratings
51.9%
Success rate
4.2%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintained: Buy | $338 | $271.83 | +24.34% | 19 | Oct 1, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $300 → $325 | $295.01 | +10.17% | 25 | Sep 25, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $283 | $285.45 | -0.86% | 22 | Sep 15, 2026 | |
| CVS CVS Health | Reiterated: Buy | $110 | $85.69 | +28.37% | 60 | Aug 26, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $81 | $56.75 | +42.73% | 12 | Aug 19, 2026 | |
| EVH Evolent Health | Rated: Buy | $5 → $6 | $3.49 | +71.92% | 50 | Aug 17, 2026 | |
| CAH Cardinal Health | Rated: Buy | $275 → $280 | $222.50 | +25.84% | 40 | Aug 13, 2026 | |
| DRIO DarioHealth | Rated: Hold | $11 → $8 | $6.73 | +18.87% | 18 | Aug 12, 2026 | |
| GDRX GoodRx Holdings | Rated: Buy | $4 → $5 | $3.29 | +51.98% | 37 | Aug 11, 2026 | |
| MDLN Medline | Rated: Buy | $53 → $45 | $34.70 | +29.68% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $300.25 | +33.22% | 51 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $989 → $1,006 | $853.81 | +17.82% | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $13.58 | -11.63% | 21 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $23 | $19.95 | +15.29% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $197 | $169.99 | +15.89% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $5.80 | +3.45% | 59 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $25.34 | +65.75% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $22.49 | +2.27% | 7 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $213 → $288 | $268.85 | +7.12% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $419 → $492 | $624.18 | -21.18% | 15 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.14 | +55.64% | 21 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $5.26 | +185.17% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $25.00 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $102.56 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.95 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $204.21 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.000001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $1.3 | $0.0001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $415 | $367.08 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $395 | $388.82 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $30.84 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $80 | $62.12 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $410 → $460 | $381.57 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $189.10 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $29 | $34.05 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $21.25 | n/a | 1 | Feb 25, 2014 |
The Cigna Group
Oct 1, 2026
Maintained: Buy
Price Target: $338
Current: $271.83
Upside: +24.34%
Charles River Laboratories International
Sep 25, 2026
Rated: Buy
Price Target: $300 → $325
Current: $295.01
Upside: +10.17%
Veeva Systems
Sep 15, 2026
Reiterated: Buy
Price Target: $283
Current: $285.45
Upside: -0.86%
CVS Health
Aug 26, 2026
Reiterated: Buy
Price Target: $110
Current: $85.69
Upside: +28.37%
BrightSpring Health Services
Aug 19, 2026
Reiterated: Buy
Price Target: $81
Current: $56.75
Upside: +42.73%
Evolent Health
Aug 17, 2026
Rated: Buy
Price Target: $5 → $6
Current: $3.49
Upside: +71.92%
Cardinal Health
Aug 13, 2026
Rated: Buy
Price Target: $275 → $280
Current: $222.50
Upside: +25.84%
DarioHealth
Aug 12, 2026
Rated: Hold
Price Target: $11 → $8
Current: $6.73
Upside: +18.87%
GoodRx Holdings
Aug 11, 2026
Rated: Buy
Price Target: $4 → $5
Current: $3.29
Upside: +51.98%
Medline
Aug 10, 2026
Rated: Buy
Price Target: $53 → $45
Current: $34.70
Upside: +29.68%
Aug 9, 2026
Reiterated: Buy
Price Target: $400
Current: $300.25
Upside: +33.22%
Aug 6, 2026
Rated: Buy
Price Target: $989 → $1,006
Current: $853.81
Upside: +17.82%
Aug 5, 2026
Rated: Hold
Price Target: $8 → $12
Current: $13.58
Upside: -11.63%
Aug 4, 2026
Reiterated: Buy
Price Target: $18 → $23
Current: $19.95
Upside: +15.29%
Aug 3, 2026
Rated: Buy
Price Target: $197
Current: $169.99
Upside: +15.89%
Aug 3, 2026
Reiterated: Hold
Price Target: $6
Current: $5.80
Upside: +3.45%
Aug 3, 2026
Reiterated: Buy
Price Target: $42
Current: $25.34
Upside: +65.75%
Aug 2, 2026
Reiterated: Hold
Price Target: $23
Current: $22.49
Upside: +2.27%
Jul 29, 2026
Rated: Buy
Price Target: $213 → $288
Current: $268.85
Upside: +7.12%
Jul 23, 2026
Rated: Hold
Price Target: $419 → $492
Current: $624.18
Upside: -21.18%
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $5.14
Upside: +55.64%
Nov 13, 2025
Reiterated: Buy
Price Target: $15
Current: $5.26
Upside: +185.17%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $25.00
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $102.56
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $24.95
Upside: n/a
Oct 30, 2023
Reiterated: Buy
Price Target: $170
Current: $204.21
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Reiterated: Sell
Price Target: $9 → $1.3
Current: $0.0001
Upside: n/a
Apr 16, 2021
Reiterated: Buy
Price Target: $370 → $415
Current: $367.08
Upside: n/a
Apr 14, 2021
Reiterated: Buy
Price Target: $360 → $395
Current: $388.82
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $30.84
Upside: n/a
Feb 8, 2021
Reiterated: Buy
Price Target: $74 → $80
Current: $62.12
Upside: n/a
Feb 1, 2021
Reiterated: Hold
Price Target: $410 → $460
Current: $381.57
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $189.10
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: $30 → $29
Current: $34.05
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $21.25
Upside: n/a